(Q57415016)

1

0 references

A Lundin

2

0 references

F Murray

3

0 references

L Mansouri

4

0 references

S Knuutila

5

0 references

C Sundström

6

0 references

A Laurell

7

0 references

B Sander

9

0 references

R Rosenquist

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target

10

0 references

publication date

1 July 2011

0 references

published in

Leukemia

0 references

volume

25

0 references

issue

12

0 references

page(s)

1904-1908

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Shaping genetic alterations in human cancer: the p53 mutation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

TP53 mutations in human cancers: origins, consequences, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162

inferred from DOI database lookup

7 January 2021

based on heuristic

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.162